Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults

NCT04315948 is registered in ClinicalTrials.gov with Institut National de la Santé Et de la Recherche Médicale, France as lead sponsor.

NCT NCT04315948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04315948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Phase
Phase 3
Overall status
Completed
Start date
March 22, 2020
Completion date
September 25, 2023
Enrollment
1,552 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection